DCB Newsletter #11/23 – Patient and Public Involvement

DCB Newsletter #11/23 – Patient and Public Involvement

Dear Community – We are happy to provide you with a new episode of our newsletter series called “INSIDE DCB” – this time with a focus on patient and public involvement (PPI)!

At DCB, we are very passionate about patient- and user-centric research and product development. It is important to us to involve those living with diabetes at every step of the way. In this newsletter, read more about how we do that and how you yourself can get involved!

Patient and public involvement is defined as “research done with or by patients and the public, not to, about or for them. It is about working collaboratively with patients and the public and sharing decision-making” [1]. It is not only about engaging the public to focus on awareness, nor is it about having patients merely participate in clinical studies.  

At DCB, we aim to involve people living with diabetes at every step of the way and in all our processes – whether that be in the mentoring of our annual DCB Open Innovation Challenge, in our clinical research studies or in other decision processes. 

PPI offers various benefits for researchers and companies. Most importantly, people living with a condition often know best which topics from their life remain under-researched and under-represented. Especially for translational research, which focuses on transferring scientific research into innovative product development, it can also uncover unmet needs that still need solutions. Altogether, involving those living with a condition in research processes can result in more impact overall. 

DCB Patient Leaders

As part of our efforts to involve the diabetes community in our decisions and activities, we established a board of DCB patient leaders roughly two years ago. Our patient leaders represent lived diabetes experience in different parts of the world – from Switzerland all the way to Singapore. We greatly value the voices of those living with diabetes and believe that all processes should involve those with lived experience. Because after all, research and product development is being done because of and for those living with diabetes! To make it truly user-centric and impactful, we need to properly involve those with a sound judgment and lived experience of it. 

Patient and Public Involvement Event at DCB

Just recently, we hosted an event for patient and public involvement at our premises in Berne. In cooperation with the University of Bern and the Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism (UDEM) at the University Hospital of Bern, we invited participants of our past research studies, people living with diabetes, researchers and the DCB team. Together, we all discussed past study outcomes as well as visions for future patient and public involvement.  

 We live and breathe patient and public involvement at DCB and we are always on the hunt for new innovative methods and activities. If you are interested or want to contribute your thoughts, please don’t hesitate to reach out and get involved with us!  

Thanks so much for reading and we’ll provide you with the next episode of this series soon!  

[1] What is patient and public involvement?  NIHR Oxford Biomedical Research Centre. https://oxfordbrc.nihr.ac.uk/ppi/ppi-researcher-guidance/what-is-patient-and-public-involvement/ 

This post was previously published in Linkedin. Click here to see the original publication.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB Supports enhance-d to Improve Diabetes Self-Management

DCB Supports enhance-d to Improve Diabetes Self-Management

DCB Supports enhance-d to Improve Diabetes Self-Management

DCB supports enhance-d, a 2021 Innovation CHallenge alumni, in combining real-time diagnostics across every aspect of the digital diabetes experience with AI-powered analytics and visualisations to see, diagnose and explain glucose self-management.

Making Sense of Diabetes Data to Inform Self-Management

enhance-d stands for improved self-management for people with diabetes using a simple digital solution. CGM and other portable data allows an understanding of how pharmacologic, behavioural, dietary and activity-based interventions contribute to changes in glucose profiles – and how users can take action based on these findings. 

DCB is happy to support this valuable venture with 150’000 CHF financially and in-kind support for product development and research.

Learn more about the collaboration on our projects website and understand how a comprehensive and holistic approach to diabetes management, incorporating various data sources, can lead to better patient outcomes.

More recent projects

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

Greta Ehlers and Dr. Stefanie Hofer: Research & Patient Centricity

Greta Ehlers and Dr. Stefanie Hofer: Research & Patient Centricity

Greta Ehlers and Dr. Stefanie Hofer: Research & Patient Centricity

Recently, Greta Ehlers from our Business Development Team and Dr. Stefanie Hofer from our Clinical Research Team joined Tinotenda Dzikiti on his podcast “The Diabetic Mogul”, talking about research and patient centricity at DCB.

Research and Patient Centricity at DCB

In this podcast episode, Greta Ehlers and Dr. Stefanie Hofer from the DCB team give insights into their own lives with type 1 diabetes as well as their professional backgrounds in the diabetes field. In doing so, they specifically delve into the research we do at DCB and our strong commitment to patient centricity.

You can listen to the podcast below:

    Research & Patient Centricity are Essential

    About “The Diabetic Mogul” podcast

    “The Diabetic Mogul Podcast”, is hosted by Tinotenda Dzikiti (Certified Diabetes Educator) and Konstantina Taki (Medical Doctor) and who are Patient Advocates. Both Tino & Konna are co-hosting a series of podcast episodes, as they envision to inspire, empower, encourage and educate the community to prevent/manage diabetes. Their hope is that “everyone could get involved, get engaged, and come up together to create the change that this World needs.”

      More recent news

      Sign up for our newsletter and stay up to date.

      * Pflichtfelder
      DSGVO *

      DCB Research AG

      Freiburgstrasse 3
      3010 Bern
      Switzerland

      DCB Innovation Challenge: Meet the Top 3 Diabetes Devices 2023!

      DCB Innovation Challenge: Meet the Top 3 Diabetes Devices 2023!

      DCB Innovation Challenge: Meet the Top 3 Diabetes Devices 2023!

      The DCB Innovation Challenge 2023 is entering its next round in the category Diabetes Devices! After rigorous evaluation and deliberation, the jury chose these three start-ups to move on to the bootcamp and finale!

      Meet our Top 3:

      Greta Preatoni (CH): MY-SENSATION – Reducing pain and restoring touch in diabetic neuropathy through a fully wearable non-invasive neuromodulation system

      “We developed a unique wearable device that restores the sense of touch and decreases pain through a non-invasive electrical nerve stimulation driven by AI algorithms. Thanks to years of research, we achieved a carefully designed electrode placement and optimal stimulation parameters, that can target directly the nerves with a pleasant stimulation, hence reducing neuropathic pain by more than 40% after just one use.”

      Robert Wylie (IE): Fada Medical – 30-day insulin delivery technology

      “We are proud to unveil our new technology that we have developed that can extend an infusion set cannula’s performance for up to 30 days to support long term insulin pump use for people with type 1 diabetes. We use a first-of-its-kind method to successfully delivery a therapeutic, such as insulin, into subcutaneous tissue and past any blockage that can occur from the foreign body response.”

      Hélène Lefebvre (FR) : Eclypia – Non-Invasive continuous glucose monitoring

      “Eclypia is developing a unique non-invasive sensing platform targeting health and wellness. Its first product is a non-invasive Continuous Glucose Monitoring device built on outstanding new and disruptive photonics technologies. At Eclypia, we are driven by excellence and a multi-expertise global approach to tackle technological, physiological and algorithmic challenges.”

      We are looking forward to entering this next round of our Innovation Challenge: a one week bootcamp in the Swiss mountains and the grand finale on 9 November!

        Download the PDF Overview

        More recent news

        Sign up for our newsletter and stay up to date.

        * Pflichtfelder
        DSGVO *

        DCB Research AG

        Freiburgstrasse 3
        3010 Bern
        Switzerland